What's new

Orphan designation: Lactobacillus plantarum Treatment of amyotrophic lateral sclerosis, 16/12/2019 Withdrawn

Orphan designation: Lactobacillus plantarum Treatment of amyotrophic lateral sclerosis, 16/12/2019 Withdrawn

Apr 9, 2025 - 09:35
 0
Orphan designation: Lactobacillus plantarum Treatment of amyotrophic lateral sclerosis, 16/12/2019 Withdrawn
Orphan designation: Lactobacillus plantarum Treatment of amyotrophic lateral sclerosis, 16/12/2019 Withdrawn
Read More

Tags:

Previous Article

Orphan designation: Unesbulin Treatment of soft tissue sarcoma, 10/12/2021 Withd...

Next Article

Orphan designation: Alrefimotide acetate,riletamotide acetate,tapderimotide acet...

Related Posts

Human medicines European public assessment report (EPAR): Uplizna, inebilizumab, Date of authorisation: 25/04/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025  0

Scientific and technical recommendations: Veterinary Medicines Regulation

Scientific and technical recommendations: Veterinary Me...

Apr 3, 2025  0

Human medicines European public assessment report (EPAR): Nexavar, sorafenib, Date of authorisation: 19/07/2006, Revision: 35, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 28, 2025  0